Association Between Inflammatory Markers and Cognitive Function in Adults With Bipolar Disorder: A Systematic Review
Acta Psychiatrica Scandinavica · 2025
DOI: 10.1111/acps.13824 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Acta Psychiatrica Scandinavica, 2025. Verfasst von David R A Coelho und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neuropsychiatry and Neuromodulation, Massachusetts General Hospital, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Bipolar Disorder, Cognitive Dysfunction, Inflammation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIMH NIH HHS.
Abstract (Originalsprache)
Introduction
Bipolar disorder (BD) is frequently associated with cognitive dysfunction, which can significantly impact the quality of life and functional recovery of affected individuals. Growing evidence suggests that inflammation may contribute to the cognitive dysfunction observed in BD.
Methods
We conducted a systematic review following PRISMA guidelines, searching six databases on March 23, 2023 (PubMed, Embase, Cochrane Library, Web of Science, PsycINFO, and ClinicalTrials.gov ), with the aim of identifying studies that examined the relationship between peripheral or central inflammatory markers and cognitive function in adults with BD. Studies involving animals, abstracts, protocols, reviews, and non‐English publications were excluded. The quality of included studies was assessed using the Risk of Bias in Non‐Randomized Studies—of Exposure (ROBINS‐E). A narrative synthesis was completed, stratifying results based on the associations between inflammatory markers and cognitive domains in BD. The review protocol was pre‐registered in PROSPERO (CRD42023415437).
Results
Out of 2680 identified records, 25 studies involving 3567 adults with BD (mean age: 43.6 years; 1839 females and 1728 males) met the inclusion criteria. Seventeen studies were classified as low risk of bias, seven as having some concerns, and one as high risk. Elevated levels of C‐reactive protein (CRP), tumor necrosis factor‐alpha (TNF‐α), interleukin‐6 (IL‐6), and interleukin‐1 receptor antagonist (IL‐1Ra) were most commonly associated with cognitive dysfunction in domains such as executive function, processing speed, and memory. Findings for other inflammatory markers were less consistent. Most studies relied on cross‐sectional designs, which limit causal interpretations.
Conclusion
This review found a consistent association between inflammation and cognitive dysfunction in BD, particularly involving CRP, TNF‐α, IL‐6, and IL‐1RA in areas such as executive function, processing speed, and memory. Targeting inflammation may offer a promising approach to mitigating these cognitive challenges. Future studies should prioritize longitudinal designs, standardized cognitive assessments, and the exploration of central inflammatory markers to better understand the neurobiological processes underlying cognitive dysfunction in BD. These findings may help inform the development of adjunctive anti‐inflammatory strategies to support cognitive health in individuals with BD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Neuropsychiatry and Neuromodulation, Massachusetts General Hospital, Boston, Massachusetts, USA.
- Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA.
- Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.
- Department of Psychiatry, Brigham and Women's Hospital, Boston, Massachusetts, USA.
- Department of Anatomy, Institute of Biomedical Sciences, University of São Paulo, São Paulo, São Paulo, Brazil.
- Treadwell Library, Massachusetts General Hospital, Boston, Massachusetts, USA.
ORCID-Profile: David R A Coelho, Jennifer Nicoloro Santabarbara, Marzieh Majd, Willians Fernando Vieira, Olindo Assis Martins-Filho, Lilian Maria Garcia Bahia-Oliveira, Joshua D Salvi, Paolo Cassano, Katherine E Burdick
Förderung
- NIMH NIH HHS
Zitieren
APA
Coelho, D. R. A., Santabarbara, J. N., Majd, M., Vieira, W. F., De Laney, M., Lydston, M., Martins-Filho, O. A., Bahia-Oliveira, L. M. G., Salvi, J. D., Cassano, P., & Burdick, K. E. (2025). Association Between Inflammatory Markers and Cognitive Function in Adults With Bipolar Disorder: A Systematic Review. Acta Psychiatrica Scandinavica. https://doi.org/10.1111/acps.13824
Vancouver
Coelho DRA, Santabarbara JN, Majd M, Vieira WF, De Laney M, Lydston M, et al. Association Between Inflammatory Markers and Cognitive Function in Adults With Bipolar Disorder: A Systematic Review. Acta Psychiatrica Scandinavica. 2025. doi:10.1111/acps.13824
BibTeX
@article{Coelho2025,
author = {Coelho, David R A and Santabarbara, Jennifer Nicoloro and Majd, Marzieh and Vieira, Willians Fernando and De Laney, Maura and Lydston, Melis and Martins-Filho, Olindo Assis and Bahia-Oliveira, Lilian Maria Garcia and Salvi, Joshua D and Cassano, Paolo and Burdick, Katherine E},
title = {Association Between Inflammatory Markers and Cognitive Function in Adults With Bipolar Disorder: A Systematic Review},
journal = {Acta Psychiatrica Scandinavica},
year = {2025},
doi = {10.1111/acps.13824}
}
EUVIMED